CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study
Objective: To test if alpha-synuclein (α-syn) levels in CSF, plasma and saliva predict PD status in the BioFind cohort, and to test whether α-syn levels…Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson disease
Objective: To evaluate the potential anti-parkinson activity of PTUPB (4-(5-phenyl-3-{3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl}-pyrazol-1-yl)-benzenesulfonamide) a dual inhibitor of soluble Epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2) against rotenone induced mitochondrial dysfunction,…3D image as a complimentary assist in patients with Parkinson’s disease
Objective: To assist patients with PD to overcome the fear of stair ascent and descent with help of 3D effect staircase Background: Since walking on…Falls characteristics of male and female patients with Parkinson’s disease (PD)
Objective: To compare Falls risk characteristics in male and female PD patients attending a multidisciplinary Movement disorders clinic. Background: Parkinson’s disease is commoner in males.…Multidisciplinary intensive outpatient rehabilitation program for patients with advanced Parkinson’s disease: feasibility and primary proof of concept
Objective: To describe as a proof of concept our experience with a multidisciplinary, intensive out-patient rehabilitation program (MIOR) for advanced PD patients. Background: Intensive, multi-dimensional…In-patient Parkinson courses and caregiver burden
Objective: To find out whether a 10 to 14 days group-based in-patient rehabilitation course for patients with Parkinson disease and their caregivers has any long-term…The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis
Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study
Objective: -the efficacy of the anti-CD20 antibody, Rituximab, in the treatment of patients with Stiff-person syndrome Background: SPS is a rare autoimmune progressive disorder of…Characterization of Pisa syndrome in Parkinson’s disease.
Objective: This study has two main objectives. The first objective is to elucidate the effects of distraction and alteration of sensorimotor inputs (visual and proprioceptive…Elevated GM3 Plasma Concentration in Idiopathic Parkinson’s Disease: a Lipidomics Analysis
Objective: To test the association between plasma lipids and Parkinson disease (PD) diagnosis. Background: PD is a common neurodegenerative disease whose pathological hallmark is the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.